Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 5
2013 3
2014 11
2015 5
2016 8
2017 7
2018 5
2019 7
2020 5
2021 5
2022 3
2023 5
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ; DECISION investigators. Brose MS, et al. Lancet. 2014 Jul 26;384(9940):319-28. doi: 10.1016/S0140-6736(14)60421-9. Epub 2014 Apr 24. Lancet. 2014. PMID: 24768112 Free PMC article. Clinical Trial.
Neoadjuvant Therapy in Differentiated Thyroid Cancer.
Dang RP, McFarland D, Le VH, Camille N, Miles BA, Teng MS, Genden EM, Misiukiewicz KJ. Dang RP, et al. Among authors: misiukiewicz kj. Int J Surg Oncol. 2016;2016:3743420. doi: 10.1155/2016/3743420. Epub 2016 Sep 22. Int J Surg Oncol. 2016. PMID: 27747102 Free PMC article. Review.
Taxanes in cancer of the head and neck.
Misiukiewicz K, Gupta V, Bakst R, Posner M. Misiukiewicz K, et al. Anticancer Drugs. 2014 May;25(5):561-70. doi: 10.1097/CAD.0000000000000086. Anticancer Drugs. 2014. PMID: 24534821 Review.
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
Hanna GJ, Roof SA, Jabalee J, Rettig EM, Ferrandino R, Chen S, Posner MR, Misiukiewicz KJ, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Gupta P, Kuperwasser C, Del Vecchio Fitz C, Berger BM. Hanna GJ, et al. Among authors: misiukiewicz kj. Clin Cancer Res. 2023 Oct 13;29(20):4306-4313. doi: 10.1158/1078-0432.CCR-23-1478. Clin Cancer Res. 2023. PMID: 37566241 Free PMC article.
Management of Older Adults with Locally Advanced Head and Neck Cancer.
Dickstein DR, Lehrer EJ, Hsieh K, Hotca A, Jones BM, Powers A, Sharma S, Liu J, Gupta V, Mell L, Husain Z, Kirke D, Misiukiewicz K, Posner M, Genden E, Bakst RL. Dickstein DR, et al. Among authors: misiukiewicz k. Cancers (Basel). 2022 Jun 5;14(11):2809. doi: 10.3390/cancers14112809. Cancers (Basel). 2022. PMID: 35681789 Free PMC article. Review.
Four Difficult Thyroid Cancer Cases: Incorporating Medical Therapies.
McFarland DC, Dang RP, Miles BA, Misiukiewicz K. McFarland DC, et al. Among authors: misiukiewicz k. Semin Oncol. 2015 Dec;42(6):e83-98. doi: 10.1053/j.seminoncol.2015.09.035. Epub 2015 Sep 21. Semin Oncol. 2015. PMID: 26615140 Review. No abstract available.
67 results